Glycoside / neoplasms

Prevention of mammary tumors by treatment with cardiac glycosides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

TABLE OF CONTENTS 1. Introduction 2. Background of the Invention 2.1. Chemical Nature and Properties of the Cardiac Glycosides 2.2. Pharmacokinetics of the Cardiac Glycosides 2.3. Cardiac Glycosides and Cancer 2.4. Cancer Prevention 3. Summary of the Invention 4. Detailed Description of the

Method of treating tumors with pharmaceutical composition containing anthracycline glycosides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present invention relates to stable, rapidly soluble, lyophilised injectable preparations comprising an anthracycline glycoside, or a pharmacutically acceptable salt thereof, as the active drug substance, and to the use of said preparations in the treatment of tumours. The lyophilised

Method of treating tumors with a pharmaceutical composition containing anthracycline glycosides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present invention relates to stable, rapidly soluble, lyophilised injectable preparations comprising an anthracycline glycoside, or a pharmaceutically acceptable salt thereof, as the active drug substance, and to the use of said preparations in the treatment of tumours. The lyophilised

Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention concerns a method of determining the prognosis in cancer chemotherapy with a cardiac glycoside. In particular, the invention concerns a method for determining the probability of whether or not an in vitro or in vivo cell disease or disorder having an

Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention concerns a method of determining the prognosis in cancer chemotherapy with a cardiac glycoside. In particular, the invention concerns a method for determining the probability of whether or not an in vitro or in vivo cell disease or disorder having an

Gem-difluorinated C-glycoside compounds as anti-cancer agents

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND (a) Field The subject matter disclosed generally relates to novel chemical compounds and methods. More particularly, the invention provides novel derivatives of podophyllotoxin with a gem-difluoronated compound, having improved conformational and chemical stability, and having improved

Cardiac glycoside analogs in combination with emodin for cancer therapy

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to cancer therapeutics. More specifically it concerns the use of cardiac glycosides such as Digoxin and Quabain in combination with Emodin and its analogs for the treatment of cancer. 2. Description of the

Process for preparation of glycosides of tumor-associated carbohydrate antigens

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the preparation of novel glycosides of tumor-associated carbohydrate haptens. 2. Description of the Background Art Tumor Associated Carbohydrate Antigenic Determinants. Numerous antigens of clinical significance

C-glycoside analogues of N-(4-hydroxyphenyl)retinamide-O-glucuronide

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION Breast cancer kills thousands of women annually. While surgical intervention has saved the lives of many women, radical and partial mastectomies often prove physically and emotionally debilitating. Indeed, surgery, even when combined with chemotherapy, may still expose

C-glycoside analogues of N-(4-hydroxyphenyl)retinamide-O-glucuronide

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION Breast cancer kills thousands of women annually. While surgical intervention has saved the lives of many women, radical and partial mastectomies often prove physically and emotionally debilitating. Indeed, surgery, even when combined with chemotherapy, may still expose

Steroidal C-glycosides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The invention relates to the field of medicinal chemistry, and more specifically to steroidal glycosides wherein the glycoside is linked directly, or indirectly to a desired steroidal compound via a carbon linkage, to formulations containing such, and their use in treating

Method of treatment employing cardiac glycoside

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention concerns a method of determining the prognosis in cancer chemotherapy with a cardiac glycoside. In particular, the invention concerns a method for determining the probability of whether or not an in vitro or in vivo cell disease or disorder having an

Pharmaceutical compositions containing anthracycline glycosides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present invention relates to stable, rapidly soluble, lyophilised injectable preparations comprising an anthracycline glycoside, or a pharmaceutically acceptable salt thereof, as the active drug substance, and to the use of said preparations in the treatment of tumours. The lyophilised

Pharmaceutical compositions containing anthracycline glycosides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present invention relates to stable, rapidly soluble, lyophilised injectable preparations comprising an anthracycline glycoside, or a pharmaceutically acceptable salt thereof, as the active drug substance, and to the use of said preparations in the treatment of tumours. The lyophilised

Neoplasmic compounds: sugar esters and glycosides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND AND SUMMARY OF INVENTION The compounds of the invention and the pharmaceutically acceptable acid-addition salts thereto relate to and are useful as active ingredients for pharmaceuticals, especially for topical administration. Similar compounds have been used in the treatment of acne and

glycoside/neoplasms

Prevention of mammary tumors by treatment with cardiac glycosides

Method of treating tumors with pharmaceutical composition containing anthracycline glycosides

Method of treating tumors with a pharmaceutical composition containing anthracycline glycosides

Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside

Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside

Gem-difluorinated C-glycoside compounds as anti-cancer agents

Cardiac glycoside analogs in combination with emodin for cancer therapy

Process for preparation of glycosides of tumor-associated carbohydrate antigens

C-glycoside analogues of N-(4-hydroxyphenyl)retinamide-O-glucuronide

C-glycoside analogues of N-(4-hydroxyphenyl)retinamide-O-glucuronide

Steroidal C-glycosides

Method of treatment employing cardiac glycoside

Pharmaceutical compositions containing anthracycline glycosides

Pharmaceutical compositions containing anthracycline glycosides

Neoplasmic compounds: sugar esters and glycosides

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen